Bigbear Pharmaceutical·Medication Guide

• FDA Approves Osimertinib for Treatment of EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer

  On November 16, 2015, the U.S. Food and Drug Administration (FDA) granted accelerated approval to osimertinib for the treatment of patients with advan···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 114

• Pralsetinib Instructions

  Pralsetinib was approved for marketing by the U.S. Food and Drug Administration (FDA) in September 2020, and subsequently approved in several countrie···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 98

• Detailed Product Information for Pralsetinib: Indications, Dosage, Side Effects, and Precautions

  Pralsetinib is a potent, highly selective RET tyrosine kinase inhibitor developed by Blueprint Medicines, Inc. It is used to treat RET fusion-positive···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 98

• Detailed Product Information for Pralsetinib: Indications, Dosage, Side Effects, and Precautions

  Pralsetinib is a potent, highly selective RET tyrosine kinase inhibitor developed by Blueprint Medicines, Inc. It is used to treat RET fusion-positive···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 100

• Side effects and adverse reactions of pralatinib

  Pralsetinib is a receptor tyrosine kinase (RET) inhibitor. It was approved for marketing by the US FDA in 2020.Side effects requiring immediate medica···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 101

• FDA Approves Pravlatinib (Gavreto) for Regular Treatment of Non-Small Cell Lung Cancer with RET Gene

  On August 9, 2023, the U.S. Food and Drug Administration (FDA) granted regular approval to pravlatinib (Gavreto, Genentech) for the treatment of adult···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 102

• FDA Approves Pramintinib (Gavreto) for the Treatment of Adult Patients with Metastatic RET Fusion-Po

  On September 4, 2020, Genentech, a Roche company, announced that the U.S. Food and Drug Administration (FDA) has approved pramintinib (Gavreto) for th···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 101

• Pralsetinib Dosage and Administration: Common Dosage and Dosage Adjustment

  Pralsetinib, developed by Blueprint Medicines, is an oral, highly selective, and potent RET inhibitor.Common Dosages for Pralsetinib1. Adult Non-Small···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 105

• Tagrisso Generic Cost vs. Brand Name Osimertinib: Is There a Cheaper Option?

  Osimertinib is a targeted therapy for the treatment of certain types of non-small cell lung cancer. Currently, its price in China varies depending on ···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 114

• Managing Osimertinib Side Effects: A Complete Guide to Symptoms, Grades, and How to Cope

  Osimertinib is a targeted therapy for non-small cell lung cancer. Common side effects include skin reactions (rash, dryness), gastrointestinal discomf···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 115

• Osimertinib 80mg Price in USA, UK & India: A Complete Cost Comparison

  The price of osimertinib varies depending on the dosage, region, and medical insurance policy, currently ranging from several thousand to tens of thou···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 116

• Osimertinib 80mg Price in USA, UK & India: A Complete Cost Comparison

  The price of osimertinib varies depending on the dosage, region, and medical insurance policy, currently ranging from several thousand to tens of thou···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 112

• Osimertinib for Lung Cancer: What Is the Monthly Treatment Cost?

  The price of osimertinib varies depending on the strength, region, purchase channel, and medical insurance policy. The specific price in the domestic ···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 110

• Legitimate Purchase Methods for Olaparib

  Olaparib is a targeted therapeutic agent used for cancers associated with BRCA gene mutations, widely applied in patients with ovarian cancer, breast ···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 106

• Latest Price of Olaparib in 2026

  Olaparib is indicated for the maintenance treatment of adult patients with platinum‑sensitive relapsed epithelial ovarian cancer, fallopian tube cance···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 112